Every Cure and BioPhy launch partnership on drug repurposing
EveryCure will leverage BioLogicAI, BioPhy’s predictive AI engine, to assess drug-disease matches
Read more...I have just returned from the two-day quarterly private equity conference hosted by the Infusion Capital Private Equity Group (https://www.infusioncapitalgroup.com/), held this time in Las Vegas. While there were several wonderful NON-tech. investment opportunities presented to the members, only one internet-based opportunity made the grade . . . and with an S1 filing already prepared (for an upcoming IPO within the next few months), this one is something that you may want to learn more about . . . and fast! The mystery surrounding this privately held (tightly held) "next big thing" is soon to be revealled on a much larger scale.
A well-produced DVD quality media presentation may be viewed at: https://peoplejar.com/dvd
EveryCure will leverage BioLogicAI, BioPhy’s predictive AI engine, to assess drug-disease matches
Read more...The contract will make it easier for state agencies to evaluate and implement Fusion's technology
Read more...The new office marks OpenAI's first location in Asia
Read more...